Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
23. Februar 2022 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO today announced they have reached agreement on a broad license for BICO and its affiliate companies to...
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18. Februar 2022 16:00 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo”), today announced that it has granted a stock option to purchase 50,000 shares of common stock to one...
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
18. Februar 2022 13:00 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D...
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
02. Februar 2022 12:00 ET
|
Organovo, Inc.
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that two of its patents have withstood a patent challenge, and the company provided guidance on...
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk
10. Januar 2022 12:00 ET
|
Organovo, Inc.
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in...
Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
30. November 2021 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
17. September 2021 16:10 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
02. März 2021 08:05 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced it will be featured as a presenting company at the H.C. Wainwright Global Life...
Organovo Regains Compliance with Nasdaq Minimum Bid Price Requirement
03. September 2020 16:05 ET
|
Organovo, Inc.
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price...
Organovo Announces One-for-Twenty Reverse Stock Split
17. August 2020 08:05 ET
|
Organovo, Inc.
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of...